NeOnc Technologies
Clinical-stage biotech firm focused on intranasal delivery of a novel, purified form of monoterpenes from fruits and plants, alone or with other chemotherapy agents.
Employees
Enterprise value
$208m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor investor investor | €0.0 Valuation: €0.0 | round | |
| N/A | €0.0 Valuation: €0.0 | round | |
* | N/A | $94.9m Valuation: $208m | IPO |
| Total Funding | 000k | ||
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.